Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel A Craven

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Genes & Development|September 5, 2006
S. pombe CLASP needs dynein, not EB1 or CLIP170, to induce microtubule instability and slows polymerization rates at cell tips in a dynein-dependent mannerAgnes Grallert, Christoph Beuter, Rachel A Craven, et al.
Kidney International|December 17, 2009
Upregulation of Hic-5 in glomerulosclerosis and its regulation of mesangial cell apoptosisNick Hornigold, Rachel A Craven, Jeff N Keen, et al.
Proteomics. Clinical Applications|October 3, 2012
Impact of pre-analytical factors on the proteomic analysis of formalin-fixed paraffin-embedded tissueSeonaid M Thompson, Rachel A Craven, Niroshini J Nirmalan, et al.
The Lancet. Oncology|February 2, 2008
Circulating markers of biliary malignancy: opportunities in proteomics?Glenn K Bonney, Rachel A Craven, Raj Prasad, et al.
Proteomics|January 28, 2003
Serological and proteomic evaluation of antibody responses in the identification of tumor antigens in renal cell carcinomaRichard D Unwin, Patricia Harnden, Darryl Pappin, et al.
Proteomics|October 13, 2004
Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometryRainy Mears, Rachel A Craven, Sarah Hanrahan, et al.
Proteomics|August 19, 2003
Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effectRichard D Unwin, Rachel A Craven, Patricia Harnden, et al.
Proteomics|April 2, 2009
Proteomic identification of differentially expressed plasma membrane proteins in renal cell carcinoma by stable isotope labelling of a von Hippel-Lindau transfectant cell line modelVassilis Aggelis, Rachel A Craven, Jianhe Peng, et al.
Proteomics|April 19, 2011
Shotgun proteomics of human bile in hilar cholangiocarcinomaShahid G Farid, Rachel A Craven, Jianhe Peng, et al.
Proteomics|April 6, 2006
Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinomaRachel A Craven, Anthea J Stanley, Sarah Hanrahan, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Genes & Development|September 5, 2006
S. pombe CLASP needs dynein, not EB1 or CLIP170, to induce microtubule instability and slows polymerization rates at cell tips in a dynein-dependent mannerAgnes Grallert, Christoph Beuter, Rachel A Craven, et al.
Kidney International|December 17, 2009
Upregulation of Hic-5 in glomerulosclerosis and its regulation of mesangial cell apoptosisNick Hornigold, Rachel A Craven, Jeff N Keen, et al.
Proteomics. Clinical Applications|October 3, 2012
Impact of pre-analytical factors on the proteomic analysis of formalin-fixed paraffin-embedded tissueSeonaid M Thompson, Rachel A Craven, Niroshini J Nirmalan, et al.
The Lancet. Oncology|February 2, 2008
Circulating markers of biliary malignancy: opportunities in proteomics?Glenn K Bonney, Rachel A Craven, Raj Prasad, et al.
Proteomics|January 28, 2003
Serological and proteomic evaluation of antibody responses in the identification of tumor antigens in renal cell carcinomaRichard D Unwin, Patricia Harnden, Darryl Pappin, et al.
Proteomics|October 13, 2004
Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometryRainy Mears, Rachel A Craven, Sarah Hanrahan, et al.
Proteomics|August 19, 2003
Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effectRichard D Unwin, Rachel A Craven, Patricia Harnden, et al.
Proteomics|April 2, 2009
Proteomic identification of differentially expressed plasma membrane proteins in renal cell carcinoma by stable isotope labelling of a von Hippel-Lindau transfectant cell line modelVassilis Aggelis, Rachel A Craven, Jianhe Peng, et al.
Proteomics|April 19, 2011
Shotgun proteomics of human bile in hilar cholangiocarcinomaShahid G Farid, Rachel A Craven, Jianhe Peng, et al.
Proteomics|April 6, 2006
Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinomaRachel A Craven, Anthea J Stanley, Sarah Hanrahan, et al.
Pageof 3